Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ER D538G

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

ER D538G	HER2 Negative Breast Cancer	ER D538G	HER2 Negative Breast Cancer	H3B-6545 Sensitive: C2 – Inclusion Criteria H3B-6545 Sensitive : C2	H3B-6545 Sensitive: C2 – Inclusion Criteria H3B-6545 Sensitive : C2
ER D538G	Breast Cancer	ER D538G	Breast Cancer	fulvestrant Sensitive: C2 – Inclusion Criteria fulvestrant Sensitive : C2	fulvestrant Sensitive: C2 – Inclusion Criteria fulvestrant Sensitive : C2
ER D538G	HER2 Negative Breast Cancer	ER D538G	HER2 Negative Breast Cancer	SAR439859 Sensitive: C3 – Early Trials SAR439859 Sensitive : C3	SAR439859 Sensitive: C3 – Early Trials SAR439859 Sensitive : C3
ER D538G	Breast Cancer	ER D538G	Breast Cancer	tamoxifen + fulvestrant Sensitive: C4 – Case Studies tamoxifen + fulvestrant Sensitive : C4	tamoxifen + fulvestrant Sensitive: C4 – Case Studies tamoxifen + fulvestrant Sensitive : C4
ER D538G	Hormone Receptor Positive Breast Cancer	ER D538G	Hormone Receptor Positive Breast Cancer	abemaciclib Sensitive: C4 – Case Studies abemaciclib Sensitive : C4	abemaciclib Sensitive: C4 – Case Studies abemaciclib Sensitive : C4
ER D538G	Hormone Receptor Positive Breast Cancer	ER D538G	Hormone Receptor Positive Breast Cancer	palbociclib Resistant: C4 – Case Studies palbociclib Resistant : C4	palbociclib Resistant: C4 – Case Studies palbociclib Resistant : C4
ER D538G	Estrogen Receptor Positive Breast Cancer	ER D538G	Estrogen Receptor Positive Breast Cancer	AZD9833 Sensitive: D – Preclinical AZD9833 Sensitive : D	AZD9833 Sensitive: D – Preclinical AZD9833 Sensitive : D
ER D538G	Estrogen Receptor Positive Breast Cancer	ER D538G	Estrogen Receptor Positive Breast Cancer	lasofoxifene Sensitive: D – Preclinical lasofoxifene Sensitive : D	lasofoxifene Sensitive: D – Preclinical lasofoxifene Sensitive : D
ER D538G	Breast Cancer	ER D538G	Breast Cancer	AZD9496 Sensitive: D – Preclinical AZD9496 Sensitive : D	AZD9496 Sensitive: D – Preclinical AZD9496 Sensitive : D